CSIMarket
 


Vycor Medical Inc   (VYCO)
Other Ticker:  
 

Vycor Medical Inc 's Working Capital Ratio

VYCO's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth


Vycor Medical Inc 's Current Assets grew by 18.59 % in the II Quarter 2023 sequentially, while Current Liabilities decreased, this led to improvement in Vycor Medical Inc 's Working Capital Ratio to 0.17, Working Capital Ratio remained below Vycor Medical Inc average.

Within Medical Equipment & Supplies industry 225 other companies have achieved higher Working Capital Ratio than Vycor Medical Inc in second quarter 2023. While Working Capital Ratio total ranking in the second quarter 2023 has deteriorated compared to the prior quarter from 4656 to 4760.

Explain Working Capital Ratio
How much in Current Assets VYCO´s has?
What is the value of VYCO´s Current Liabilities?


VYCO Working Capital Ratio (Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Current Liabilities Change 12.62 % 12.93 % 16.03 % 16.58 % 10.43 %
Y / Y Current Assets Change 20.35 % 1.47 % 6.15 % 3.09 % -8.94 %
Working Capital Ratio MRQ 0.17 0.14 0.14 0.16 0.15
VYCO's Total Ranking # 4760 # 4656 # 4698 # 4596 # 5195
Seq. Current Liabilities Change -0.18 % 3.59 % 0.9 % 7.94 % 0.1 %
Seq. Current Assets Change 18.59 % 0.52 % -10.59 % 12.91 % -0.02 %



Working Capital Ratio second quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 226
Healthcare Sector # 1070
Overall Market # 4760


Working Capital Ratio Statistics
High Average Low
3.84 0.67 0.13
(Jun 30 2014)   (Dec 31 2013)




Financial Statements
Vycor Medical Inc 's Current Liabilities $ 4 Millions Visit VYCO's Balance sheet
Vycor Medical Inc 's Current Assets $ 1 Millions Visit VYCO's Balance sheet
Source of VYCO's Sales Visit VYCO's Sales by Geography


Cumulative Vycor Medical Inc 's Working Capital Ratio

VYCO's Working Capital Ratio for the trailling 12 Months

VYCO Working Capital Ratio

(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Current Liabilities TTM Growth 12.62 % 12.93 % 16.03 % 16.58 % 10.43 %
Y / Y Current Assets TTM Growth 20.35 % 1.47 % 6.15 % 3.09 % -8.94 %
Working Capital Ratio TTM 0.15 0.15 0.15 0.16 0.16
Total Ranking TTM # 4246 # 4261 # 4248 # 3943 # 5103
Seq. Current Liabilities TTM Growth -0.18 % 3.59 % 0.9 % 7.94 % 0.1 %
Seq. Current Assets TTM Growth 18.59 % 0.52 % -10.59 % 12.91 % -0.02 %


On the trailing twelve months basis In Spite of the decrease in Current Liabilities in the II Quarter 2023 to $3.78 millions, cumulative Working Capital Ratio remained unchanged at 0.15 below the Vycor Medical Inc average Working Capital Ratio.
Working Capital Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 243 other companies have achieved higher Working Capital Ratio than Vycor Medical Inc . While Working Capital Ratio overall ranking has improved so far to 4246, from total ranking during the twelve months ending first quarter 2023 at 4261.

Explain Working Capital Ratio
How much in Current Assets VYCO´s has?
What is the value of VYCO´s Current Liabilities?

TTM Working Capital Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 244
Healthcare Sector # 1089
Within the Market # 4246


trailing twelve months Working Capital Ratio Statistics
High Average Low
3.01 0.65 0.14
(March 31, 2015)   (Dec. 30, 2013)




Companies with similar Working Capital Ratio in the quarter ending Jun 30 2023, within Medical Equipment & Supplies Industry Working Capital RatioJun 30 2023 MRQ Current AssetsJun 30 2023 MRQ Current Liabilities
Nemaura Medical Inc   0.42 $ 7.473  Millions$ 17.605  Millions
Allurion Technologies Inc   0.41 $ 37.066  Millions$ 89.886  Millions
Guided Therapeutics Inc   0.41 $ 2.029  Millions$ 4.936  Millions
T2 Biosystems Inc   0.36 $ 23.870  Millions$ 66.056  Millions
Nu med Plus Inc   0.31 $ 0.037  Millions$ 0.118  Millions
Biotricity Inc   0.29 $ 4.401  Millions$ 15.098  Millions
Vystar Corporation  0.25 $ 1.529  Millions$ 5.999  Millions
Yubo International Biotech Limited  0.24 $ 0.701  Millions$ 2.949  Millions
Invo Bioscience Inc   0.19 $ 0.842  Millions$ 4.469  Millions
Seastar Medical Holding Corporation  0.17 $ 2.332  Millions$ 13.782  Millions
Vycor Medical Inc   0.17 $ 0.624  Millions$ 3.779  Millions
Arch Therapeutics Inc   0.16 $ 1.560  Millions$ 9.579  Millions
Qhslab Inc   0.12 $ 0.250  Millions$ 2.065  Millions
Therapeutic Solutions International Inc   0.12 $ 0.223  Millions$ 1.875  Millions
Spectral Ai Inc   0.11 $ 0.579  Millions$ 5.284  Millions
Bellevue Life Sciences Acquisition Corp   0.11 $ 0.059  Millions$ 0.541  Millions
Bioplus Acquisition Corp   0.10 $ 0.197  Millions$ 1.979  Millions
Altair International Corp   0.09 $ 0.033  Millions$ 0.350  Millions
Northview Acquisition Corp   0.09 $ 0.236  Millions$ 2.586  Millions
United Health Products Inc   0.08 $ 0.175  Millions$ 2.169  Millions
Non Invasive Monitoring Systems Inc  0.07 $ 0.023  Millions$ 0.335  Millions
Blueriver Acquisition Corp   0.06 $ 0.148  Millions$ 2.391  Millions
Odyssey Health Inc   0.06 $ 0.406  Millions$ 6.612  Millions
Legacy Ventures International Inc  0.06 $ 0.002  Millions$ 0.039  Millions
Marizyme Inc   0.05 $ 1.059  Millions$ 20.822  Millions
Altitude Acquisition Corp   0.05 $ 0.116  Millions$ 2.314  Millions
Envoy Medical Inc   0.04 $ 0.398  Millions$ 9.348  Millions
Sigyn Therapeutics Inc   0.04 $ 0.129  Millions$ 3.246  Millions

Date modified: 2023-08-21T10:33:23+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com